Granite Point Capital Management’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-263,596
Closed -$4.22M 176
2021
Q2
$4.22M Sell
263,596
-452,730
-63% -$6.26M 0.16% 43
2021
Q1
$8.86M Sell
716,326
-530,456
-43% -$8.13M 0.33% 23
2020
Q4
$13.9M Sell
1,246,782
-53,218
-4% -$400K 0.71% 13
2020
Q3
$6.32M Buy
+1,300,000
New +$4.93M 0.34% 35

Other funds holding STIM

Granite Point Capital Management's STIM Position: Q3 2021 in Review

Granite Point Capital Management sold out of Neuronetics (STIM) in Q3 2021, closing a stake of 263,596 shares — an estimated $4.22M sold.

Granite Point Capital Management first reported a position in STIM in Q3 2020 and held it in 4 quarters. The position peaked at $13.9M in Q4 2020. 97 funds tracked by Wall St. Rank hold STIM as of Q3 2021.

  • Granite Point Capital Management reported no remaining Neuronetics position as of Q3 2021 after selling out during the quarter.
  • Granite Point Capital Management sold 263,596 Neuronetics shares in Q3 2021, an estimated $4.22M.
  • Granite Point Capital Management first reported a position in Neuronetics in Q3 2020 and held it in 4 quarters.
  • Granite Point Capital Management's Neuronetics position peaked at $13.9M in Q4 2020.
  • 97 funds tracked by Wall St. Rank held Neuronetics as of Q3 2021.

Based on Granite Point Capital Management's 13F filing for Q3 2021, filed 10 Nov 2021.